Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
WISP3 encodes a member of the WNT1 inducible signaling pathway (WISP) protein subfamily, which belongs to the connective tissue growth factor (CTGF) family. Additionally we are shipping Wnt1 Inducible Signaling Pathway Protein 3 Proteins (7) and Wnt1 Inducible Signaling Pathway Protein 3 Kits (3) and many more products for this protein.
Showing 10 out of 41 products:
Human Polyclonal WISP3 Primary Antibody for EIA, IHC (p) - ABIN358747
Tanaka, Sugimachi, Shimada, Maehara, Sugimachi: Variant WISPs as targets for gastrointestinal carcinomas. in Gastroenterology 2002
Show all 5 references for ABIN358747
Human Polyclonal WISP3 Primary Antibody for IHC (p), WB - ABIN390189
Hurvitz, Suwairi, Van Hul, El-Shanti, Superti-Furga, Roudier, Holderbaum, Pauli, Herd, Van Hul, Rezai-Delui, Legius, Le Merrer, Al-Alami, Bahabri, Warman: Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. in Nature genetics 1999
Show all 3 references for ABIN390189
One paralog of mammalian wisp3 was found in zebrafish.
Overexpression of zebrafish Wisp3 protein inhibited bone morphogenetic protein (BMP) and Wnt signaling in developing zebrafish.
Studies indicate that the CYR61 (show CYR61 Antibodies) CTGF (show CTGF Antibodies) NOV (show NOV Antibodies) matricellular proteins (CCN family of proteins) comprises the members CCN1 (show CCNA2 Antibodies), CCN2 (show CTGF Antibodies), CCN3 (show NOV Antibodies), CCN4 (show WISP1 Antibodies), CCN5 (show WISP2 Antibodies) and CCN6 and have been identified in various types of cancer.
WISP3 harbored not only frameshift mutation but also mutational intratumoral heterogeneity and loss of expression, which together might play a role in tumorigenesis of GC and CRC (show CALR Antibodies) with MSI (show MSI1 Antibodies)-H by inhibiting tumor suppressor functions of WISP3.
WISP3 variant leads to the diagnosis of SEDT (show TRAPPC2 Antibodies)-PA.
Novel and recurrent mutations in WISP3 and an atypical phenotype have been described in Indian families with progressive pseudorheumatoid dysplasia.
A novel mutation c.667T>G (p.Cys223Gly) and the c.857C>G (p.Ser286*) mutation were detected in three Chinese patients with PPD (show HPD Antibodies).
This study identified 3 different WISP3 mutations in 2 unrelated Chinese families with spondyloepiphyseal dysplasia tarda with progressive arthropathy.
Suggest WISP3-Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies) axis may have role in regulating gastric cancer cell proliferation and metastasis.
Novel C223G and C252X mutations in exon 4 of the WISP3 gene are responsible for progressive pseudorheumatoid dysplasia in Chinese patients.
Results are indicative of an operational WISP3-IGF1 (show IGF1 Antibodies) regulatory loop whereby WISP3 preserves cartilage integrity by restricting IGF1 (show IGF1 Antibodies)-mediated hypertrophic changes in chondrocytes, at least partly, upon interaction with IGF1 (show IGF1 Antibodies).
A report on 11 different homozygous mutations and one instance of compound heterozygosity in the WISP3 gene in patients with progressive pseudorheumatoid dysplasia.
demonstrated that CCN6 induced the proliferation of lung fibroblasts by binding to integrin beta1, leading to the phosphorylation of FAK (show PTK2 Antibodies)(Y397).
the WISP3 gene is essential to skeletal growth or homeostasis in humans but not in mice [WISP3]
This gene encodes a member of the WNT1 inducible signaling pathway (WISP) protein subfamily, which belongs to the connective tissue growth factor (CTGF) family. WNT1 is a member of a family of cysteine-rich, glycosylated signaling proteins that mediate diverse developmental processes. The CTGF family members are characterized by four conserved cysteine-rich domains: insulin-like growth factor-binding domain, von Willebrand factor type C module, thrombospondin domain and C-terminal cystine knot-like domain. This gene is overexpressed in colon tumors. It may be downstream in the WNT1 signaling pathway that is relevant to malignant transformation. Mutations of this gene are associated with progressive pseudorheumatoid dysplasia, an autosomal recessive skeletal disorder, indicating that the gene is essential for normal postnatal skeletal growth and cartilage homeostasis. Multiple transcript variants encoding different isoforms have been found for this gene.
WNT1 inducible signaling pathway protein 3
, WNT1-inducible-signaling pathway protein 3
, WNT1-inducible-signaling pathway protein 3-like
, CCN family member 6